In this review, we addressed the main techniques used in the selection and design of aptamers and their current use in prostate cancer research, with a focus on aptamers targeting the PSMA protein used for diagnostic and therapeutic PCa research. The gene discussed is FOLH1; the disease is prostate cancer.